Come and meet our CEO Dr Afshar, and Director of Sales Dan Manak, at BIO 2016 for the latest on the KEM® portal!
Ariana hosted their regular Science Day this week – a 1-day symposium in Paris on advances in machine learning and artificial intelligence, chaired by Dr Jean Sallantin, Director of Research at the CNRS LIRMM (Laboratoire d’Informatique, de Robotique et de Micro-électronique de Montpellier) and Scientific Advisor to Ariana. […]
Dr Miralves and Dr Vaucouleur from Ariana Pharma will present their latest accomplishments in tool development for the deployment of data-driven algorithms for personalized medicine at the Sanofi France R&D Science Days event.
Our CEO, Dr Mohammad Afshar, will present at Biomarker Summit 2016 on the challenge of transforming biomarker data into clinically actionable information for personalized cancer treatment selection. […]
Dr Afshar and the Ariana team will discuss the use of a broad range of data extracted from hospital records and their impact on personalized medicine at Données de santé hospitalières en Europe : nouvelles perspectives pour la recherche clinique et l’innovation […]
Our CTO, Dr Mariana Guergova-Kuras, joins a distinguished panel of speakers at UCD/Breast-Predict event focused on prognostic and predictive tools. […]
Mohammad Afshar (CEO) presents Ariana’s Onco KEM® tool at the prestigious French American Innovation Day (FAID) 2016, gathering world renowned experts in precision medicine. […]
During his presentation at Personalised Medicines & Biomarkers 2015 Mohammad Afshar will share real-life examples of our KEM® platform application. […]
Mohammad Afshar selected to pitch the company’s novel approach to therapeutic decision-making at kick-off economic event of the France-Korea Year. […]
Ariana’s own YouTuber Mohammad Afshar will present the company most recent research in front of a distinguished international audience at Sanofi’s East Coast R&D center. […]